Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1

References

• Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007 Apr;5(4):692–699.
   PubMed Web of Science ®Google Scholar
• ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014 Oct;12(10):1580–1590.
   PubMed Web of Science ®Google Scholar
• Schulman S, Lindmarker P, Holmström M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006 Apr 4;4(4):734–742.
   PubMed Web of Science ®Google Scholar
• Arshad N, Bjøri E, Hindberg K, et al. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost. 2017 Feb;15(2):295–303.
   PubMed Web of Science ®Google Scholar
• Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017 Feb;49(2):1601792.
   PubMed Web of Science ®Google Scholar
• Klarin D, Busenkell E, Judy R, et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nature Genetics. 2019;51(11):1574–1579.
   PubMed Web of Science ®Google Scholar
• Lindström S, Wang L, Smith E, et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood. 2019;134(19):1645–1657.
   PubMed Web of Science ®Google Scholar
• Wolberg A, Rosendaal F, Weitz J, et al. Venous thrombosis. Nature Reviews. Disease Primers. 2015;1:15006.
   PubMed Web of Science ®Google Scholar
• Benincasa G, Costa D, Infante T, et al. Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: a new challenge for personalized therapy. Thrombosis Research. 2019;177:145–153.
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez I. Trehalose: is it a potential inhibitor of antithrombin polymerization? Biosci Rep. 2019;39:6.
   Google Scholar
• Olds RJ, Lane DA, Chowdhury V, et al. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry. 1993 Apr 27;32(16):4216–4224.
   PubMed Web of Science ®Google Scholar
• Egeberg O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun;15(13):516–530.
   Google Scholar
• Lijfering WM, Brouwer JL, Veeger NJ, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009 May 21;113(21):5314–5322.
   PubMed Web of Science ®Google Scholar
• Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 2000 Oct;106(7):873–878.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004 Jan 23;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Selbach M, Schwanhäusser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008 Sep 4;455(7209):58–63.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010 Oct;101(10):2087–2092.
   PubMed Web of Science ®Google Scholar
• Prieto-Vila M, Yoshioka Y, Ochiya T, et al. Biological functions driven by mRNAs carried by extracellular vesicles in cancer. Frontiers in Cell and Developmental Biology. 2021;9:620498.
   PubMed Web of Science ®Google Scholar
• Rajool Dezfuly A, Safaee A, Salehi H, et al. Therapeutic effects of mesenchymal stem cells-derived extracellular vesicles’ miRNAs on retinal regeneration: a review. Stem Cell Research & Therapy. 2021;12(1):530.
   PubMed Web of Science ®Google Scholar
• Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010 Mar 2;121(8):1022–1032.
   PubMed Web of Science ®Google Scholar
• Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007 Jun 8;100(11):1579–1588.
   PubMed Web of Science ®Google Scholar
• Liu X, Cheng Y, Zhang S, et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009 Feb 27;104(4):476–487.
   PubMed Web of Science ®Google Scholar
• Weber C, Schober A, Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets. 2010 Aug;11(8):950–956.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Zhang HX, Wang Z, et al. The predictive value of circulating microRNAs for venous thromboembolism diagnosis: a systematic review and diagnostic meta-analysis. Thromb Res. 2019 Sep;181:127–134.
   PubMed Web of Science ®Google Scholar
• Ming Z, Ding W, Yuan R, et al. Differential co-expression analysis of venous thromboembolism based on gene expression profile data. Exp Ther Med. 2016 Jun;11(6):2193–2200.
   PubMed Web of Science ®Google Scholar
• Fazzalari A, Basadonna G, Kucukural A, et al. A translational model for venous thromboembolism: microRNA expression in hibernating black bears. J Surg Res. 2021 Jan;257:203–212.
   PubMed Web of Science ®Google Scholar
• Swanson EJP, Surgery R. Prospective study of doppler ultrasound surveillance for deep venous thromboses in 1000 plastic surgery outpatients. Plast Reconstr Surg. 2020;145(1):85–96.
   Google Scholar
• Starikova I, Jamaly S, Sorrentino A, et al. Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals. Thrombosis Research. 2015;136(3):566–572.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu C, Cui HJB. Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. Bioengineered. 2021;12(1):7446–7458.
   PubMed Web of Science ®Google Scholar
• Henke PK, Varga A, De S, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1130–1137.
   PubMed Web of Science ®Google Scholar
• Downing LJ, Strieter RM, Kadell AM, et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol. 1998 Aug 1;161(3):1471–1476.
   PubMed Web of Science ®Google Scholar
• Sun X, Icli B, Wara AK, et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest. 2012 Jun;122(6):1973–1990.
   PubMed Web of Science ®Google Scholar
• Ge Q, Shen Y, Tian F, et al. Profiling circulating microRNAs in maternal serum and plasma. Molecular Medicine Reports. 2015;12(3):3323–3330.
   PubMed Web of Science ®Google Scholar
• Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005 Nov 27;33(20):e179.
   PubMed Web of Science ®Google Scholar
• Livak K, Schmittgen TJM. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif.). 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang H, Xu JJB. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma. Bioengineered. 2021;12(1):3993–4003.
   PubMed Web of Science ®Google Scholar
• Sahu A, Jha P, Prabhakar A, et al. MicroRNA-145 impedes thrombus formation via targeting tissue factor in venous thrombosis. EBioMedicine. 2017; 26:175–186.
   Google Scholar
• Feng Y, Wei G, Zhang L, et al. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered. 2021;12(1):8217–8232.
   PubMed Web of Science ®Google Scholar
• Milburn J, Ford I, Mutch N, et al. Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis. PloS One. 2013;8(7):e67799.
   PubMed Web of Science ®Google Scholar
• Caspers M, Pavlova A, Driesen J, et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. Thromb Haemost. 2012 Aug;108(2):247–257.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wang F, Liang M. SerpinC1/Antithrombin III in kidney-related diseases. Clin Sci (Lond). 2017 May 1;131(9):823–831.
   PubMed Web of Science ®Google Scholar
• Opal SM. Interactions between coagulation and inflammation. Scand J Infect Dis. 2003;35(9):545–554.
   PubMed Web of Science ®Google Scholar
• Souter PJ, Thomas S, Hubbard AR, et al. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med. 2001 Jan;29(1):134–139.
   PubMed Web of Science ®Google Scholar
• Björk I, Olson ST. Antithrombin. A bloody important serpin. Adv Exp Med Biol. 1997;425:17–33.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu X, Du X, et al. MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1. Microvasc Res. 2019 May;123:35–41.
   PubMed Web of Science ®Google Scholar
• Tian J, Adams MJ, Tay JWT, et al. Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3ʹUTR to Modulate Tissue Factor-Initiated Thrombin Generation. Thromb Haemost. 2021 Feb;121(1):4.
   PubMedGoogle Scholar
• Jiang Y, Yang Y, Zhang C, et al. Upregulation of miR-200c-3p induced by NaF promotes endothelial apoptosis by activating Fas pathway. Environ Pollut. 2020 Nov;266(Pt 1):115089.
   PubMedGoogle Scholar
• Chen D, Zhang C, Chen J, et al. miRNA-200c-3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass grafts. J Pathol. 2021 Feb;253(2):209–224.
   PubMed Web of Science ®Google Scholar
• Christopher A, Kaur R, Kaur G, et al. MicroRNA therapeutics: discovering novel targets and developing specific therapy. Perspectives in Clinical Research. 2016;7(2):68–74.
   PubMedGoogle Scholar
• Nouraee N, Mowla S. miRNA therapeutics in cardiovascular diseases: promises and problems. Frontiers in Genetics. 2015;6:232.
   PubMed Web of Science ®Google Scholar
• Zhang S, Cheng Z, Wang Y, et al. The risks of miRNA therapeutics: in a drug target perspective. Drug Design, Development and Therapy. 2021;15:721–733.
   PubMed Web of Science ®Google Scholar